• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用 UHPLC-Q/Exactive Orbitrap HRMS 同时测定犬血浆中扶正化瘀方 8 种成分的浓度及其毒代动力学研究

Simultaneous determination of eight analytes of Fuzheng Huayu recipe in beagle dog plasma by UHPLC-Q/exactive Orbitrap HRMS and its application to toxicokinetics.

机构信息

Department of Cardiology, Institute of Cardiovascular Disease of Integrated Traditional Chinese Medicine and Western Medicine, Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, China.

出版信息

Biomed Chromatogr. 2022 Apr;36(4):e5329. doi: 10.1002/bmc.5329. Epub 2022 Jan 22.

DOI:10.1002/bmc.5329
PMID:34997600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9287080/
Abstract

Fuzheng Huayu recipe (FZHY) is a Chinese patent medicine for the treatment of liver fibrosis. This study aimed to investigate the toxicokinetics of FZHY in beagle dogs after oral administration. Blood samples were collected on days 1, 15 and 28 after oral gavage of FZHY dosages of 400 or 1,200 mg/kg body weight once a day. A UHPLC-Q-Orbitrap method was developed and validated to simultaneously determine and quantify eight components of FZHY in beagle dog plasma. The times to peak concentration for eight components were18-120 min. The peak concentrations (C ) of amygdalin, genistein, daidzein and 3,4-dihydroxybenzaldehyde were 1.43-43.50 ng/ml, the areas under the concentration-time curve (AUC ) were 2.45-6,098.25 ng min/ml, and the apparent volumes of distribution (V ) were 0.05-131.23 × 10  ml/kg. The values of C of prunasin, schisantherin A, schisandrin A and schisandrin were 7.35-1,450.73 ng/ml, the values of AUC were 3,642.30-330,388.65 ng min/ml, and the values of V were 11.15-1,087.18 × 10  ml/kg. No obvious accumulation of the eight compounds was observed in beagle dogs. The results showed that the method is rapid, accurate and sensitive, and is suitable for detecting the eight analytes of FZHY. This study provides an important basis for the assessment of FZHY safety.

摘要

扶正化瘀方(FZHY)是一种治疗肝纤维化的中药专利药。本研究旨在研究 FZHY 在口服给药后犬体内的毒代动力学。在口服 FZHY 剂量为 400 或 1200mg/kg 体重,每天一次的第 1、15 和 28 天采集血样。建立并验证了一种 UHPLC-Q-Orbitrap 方法,以同时定量测定比格犬血浆中 FZHY 的 8 种成分。8 种成分的达峰时间为 18-120min。杏仁苷、染料木素、大豆苷元和 3,4-二羟基苯甲醛的峰浓度(C )为 1.43-43.50ng/ml,浓度-时间曲线下面积(AUC )为 2.45-6098.25ng min/ml,表观分布容积(V )为 0.05-131.23×10 ml/kg。Prunasin、五味子甲素、五味子丙素和五味子乙素的 C 值为 7.35-1450.73ng/ml,AUC 值为 3642.30-330388.65ng min/ml,V 值为 11.15-1087.18×10 ml/kg。在比格犬体内未观察到 8 种化合物的明显蓄积。结果表明,该方法快速、准确、灵敏,适用于检测 FZHY 的 8 种分析物。本研究为评估 FZHY 的安全性提供了重要依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d94/9287080/b797b5228edf/BMC-36-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d94/9287080/52970d9f7682/BMC-36-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d94/9287080/94429fb39e7d/BMC-36-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d94/9287080/ffe5b90f6963/BMC-36-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d94/9287080/edc1db2f7214/BMC-36-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d94/9287080/b797b5228edf/BMC-36-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d94/9287080/52970d9f7682/BMC-36-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d94/9287080/94429fb39e7d/BMC-36-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d94/9287080/ffe5b90f6963/BMC-36-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d94/9287080/edc1db2f7214/BMC-36-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d94/9287080/b797b5228edf/BMC-36-0-g002.jpg

相似文献

1
Simultaneous determination of eight analytes of Fuzheng Huayu recipe in beagle dog plasma by UHPLC-Q/exactive Orbitrap HRMS and its application to toxicokinetics.采用 UHPLC-Q/Exactive Orbitrap HRMS 同时测定犬血浆中扶正化瘀方 8 种成分的浓度及其毒代动力学研究
Biomed Chromatogr. 2022 Apr;36(4):e5329. doi: 10.1002/bmc.5329. Epub 2022 Jan 22.
2
Pharmacokinetic study of five components of Fuzheng Huayu tablets in healthy human plasma.扶正化瘀片在健康人体血浆中 5 个成分的药代动力学研究。
Biomed Chromatogr. 2024 Feb;38(2):e5782. doi: 10.1002/bmc.5782. Epub 2023 Nov 28.
3
Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.扶正化瘀方灌胃给药后正常及肝纤维化大鼠体内木脂素成分的比较药代动力学和组织分布特征。
J Ethnopharmacol. 2015 May 26;166:305-12. doi: 10.1016/j.jep.2015.03.024. Epub 2015 Mar 18.
4
Comparative pharmacokinetic and tissue distribution profiles of four major bioactive components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.扶正化瘀方口服给药后正常大鼠和肝纤维化大鼠体内四种主要生物活性成分的比较药代动力学及组织分布特征
J Pharm Biomed Anal. 2015 Oct 10;114:152-8. doi: 10.1016/j.jpba.2015.05.014. Epub 2015 May 27.
5
Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components.丹参在扶正化瘀方中体内吸收代谢成分的研究及这些成分抗肝纤维化作用的研究。
J Ethnopharmacol. 2013 Jul 9;148(2):691-700. doi: 10.1016/j.jep.2013.05.031. Epub 2013 May 22.
6
[Chinese herbal medicine Fuzheng Huayu recipe inhibits liver fibrosis by mediating the transforming growth factor-β1/Smads signaling pathway].中药扶正化瘀方通过介导转化生长因子-β1/Smads信号通路抑制肝纤维化
Zhong Xi Yi Jie He Xue Bao. 2012 May;10(5):561-8. doi: 10.3736/jcim20120512.
7
[Effect of Fuzheng Huayu recipe on CYP450 isozymes in normal and liver fibrosis rats].[扶正化瘀方对正常及肝纤维化大鼠细胞色素P450同工酶的影响]
Zhongguo Zhong Yao Za Zhi. 2015 Mar;40(6):1166-72.
8
Effects of Fuzheng Huayu recipe on entecavir pharmacokinetics in normal and dimethylnitrosamine-induced hepatic fibrosis rats.扶正化瘀方对正常及二甲基亚硝胺致肝纤维化大鼠体内恩替卡韦药代动力学的影响。
Pharm Biol. 2020 Dec;58(1):1-7. doi: 10.1080/13880209.2019.1687527.
9
Fuzheng Huayu recipe, a traditional Chinese compound herbal medicine, attenuates renal interstitial fibrosis via targeting the miR-21/PTEN/AKT axis.扶正化瘀方通过靶向 miR-21/PTEN/AKT 轴减轻肾间质纤维化。
J Integr Med. 2020 Nov;18(6):505-513. doi: 10.1016/j.joim.2020.08.006. Epub 2020 Aug 19.
10
Simultaneous determination and pharmacokinetic study of twelve bioactive compounds in rat plasma after intravenous administration of Xuebijing injection by UHPLC-Q-Orbitrap HRMS.采用 UHPLC-Q-Orbitrap HRMS 法测定静脉注射血必净注射液后大鼠血浆中 12 种生物活性成分及其药代动力学研究。
J Pharm Biomed Anal. 2017 Nov 30;146:347-353. doi: 10.1016/j.jpba.2017.09.010. Epub 2017 Sep 8.

本文引用的文献

1
Accumulation Pattern of Amygdalin and Prunasin and Its Correlation with Fruit and Kernel Agronomic Characteristics during Apricot ( L.) Kernel Development.苦杏仁苷和野黑樱苷在杏(L.)核发育过程中的积累模式及其与果实和核农艺性状的相关性
Foods. 2021 Feb 11;10(2):397. doi: 10.3390/foods10020397.
2
Fuzheng Huayu Recipe Prevented and Treated CCl4-Induced Mice Liver Fibrosis through Regulating Polarization and Chemotaxis of Intrahepatic Macrophages via CCL2 and CX3CL1.扶正化瘀方通过CCL2和CX3CL1调节肝内巨噬细胞的极化和趋化作用防治四氯化碳诱导的小鼠肝纤维化
Evid Based Complement Alternat Med. 2020 Nov 25;2020:8591892. doi: 10.1155/2020/8591892. eCollection 2020.
3
Traditional Chinese Medicine Fuzheng Huayu Prevents Development of Liver Fibrosis in Mice.
中药扶正化瘀预防小鼠肝纤维化的发生
Arch Clin Biomed Res. 2020;4(5):561-580. doi: 10.26502/acbr.50170125. Epub 2020 Oct 20.
4
Improved Pharmacokinetics and Tissue Uptake of Complexed Daidzein in Rats.大鼠中复合大豆苷元的药代动力学及组织摄取改善
Pharmaceutics. 2020 Feb 16;12(2):162. doi: 10.3390/pharmaceutics12020162.
5
Simultaneous Determination of Schisandrin and Promethazine with Its Metabolite in Rat Plasma by HPLC-MS/MS and Its Application to a Pharmacokinetic Study.高效液相色谱-串联质谱法同时测定大鼠血浆中五味子醇甲、异丙嗪及其代谢物并应用于药代动力学研究
Int J Anal Chem. 2019 Dec 9;2019:3497045. doi: 10.1155/2019/3497045. eCollection 2019.
6
Effects of Fuzheng Huayu recipe on entecavir pharmacokinetics in normal and dimethylnitrosamine-induced hepatic fibrosis rats.扶正化瘀方对正常及二甲基亚硝胺致肝纤维化大鼠体内恩替卡韦药代动力学的影响。
Pharm Biol. 2020 Dec;58(1):1-7. doi: 10.1080/13880209.2019.1687527.
7
Metabolic mechanisms of Fuzheng-Huayu formula against liver fibrosis in rats.扶正化瘀方抗大鼠肝纤维化的代谢机制。
J Ethnopharmacol. 2019 Jun 28;238:111888. doi: 10.1016/j.jep.2019.111888. Epub 2019 Apr 17.
8
The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases.扶正化瘀方防治慢性肝病的作用及机制。
Biomed Pharmacother. 2019 Jun;114:108846. doi: 10.1016/j.biopha.2019.108846. Epub 2019 Apr 7.
9
Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis.基于网络药理学和转录组学分析的扶正化瘀方活性化合物对肝实质细胞凋亡的保护作用。
Molecules. 2019 Jan 18;24(2):338. doi: 10.3390/molecules24020338.
10
Toxicity and Toxicokinetics of Amygdalin in Maesil ( Prunus mume) Syrup: Protective Effect of Maesil against Amygdalin Toxicity.苦杏仁苷在梅实(Prunus mume)糖浆中的毒性和毒代动力学:梅实对苦杏仁苷毒性的保护作用。
J Agric Food Chem. 2018 Oct 31;66(43):11432-11440. doi: 10.1021/acs.jafc.8b03686. Epub 2018 Oct 19.